Monash IVF Group Limited (ASX:MVF)

Market Cap	270.80M -9.2%
Revenue (ttm)	269.39M -0.1%
Net Income	15.16M
EPS	0.04
Shares Out	389.63M
PE Ratio	17.88
Forward PE	13.68
Dividend	0.05 (7.48%)
Ex-Dividend Date	Mar 4, 2026

Volume	165,964
Open	0.6950
Previous Close	0.6950
Day's Range	0.6900 - 0.7100
52-Week Range	0.5370 - 0.8950
Beta	0.39
Analysts	Buy
Price Target	0.81 (+16.55%)
Earnings Date	Aug 24, 2026

About Monash IVF Group

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2014
• Employees: 892
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVF

Analyst Summary

According to 6 analysts, the average rating for MVF stock is "Buy." The 12-month stock price target is $0.81, which is an increase of 16.55% from the latest price.

Price Target

$0.81

(16.55% upside)

Analyst Consensus: Buy